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Cells of the immune system are confronted with opposing pro- and anti-inflammatory signals.
Dendritic cells (DC) integrate these cues to make informed decisions whether to initiate an immune
response. Confronted with exogenous microbial stimuli, DC endogenously produce both anti- (IL-
10) and pro-inflammatory (TNFα) cues whose joint integration controls the cell’s final decision.
We combine experimental measurements with theoretical modeling to quantitatively describe the
integration mode of these opposing signals. We propose a two step integration model that modu-
lates the effect of the two types of signals: an initial bottleneck integrates both signals (IL-10 and
TNFα), the output of which is later modulated by the anti-inflammatory signal. We show that the
anti-inflammatory IL-10 signaling is long ranged, as opposed to the short-ranged pro-inflammatory
TNFα signaling. The model suggests that the population averaging and modulation of the pro-
inflammatory response by the anti-inflammatory signal is a safety guard against excessive immune
responses.
I. INTRODUCTION
Cells constantly integrate signals to adapt to their en-
vironment. In the immune system, activating signals are
critical to initiate and sustain an efficient immune re-
sponse, and co-exist with inhibitory signals in order to
avoid excessive and uncontrolled immune responses [1, 2].
Immune cells must often integrate such opposing signals,
the outcome being key to decision making between im-
munity versus tolerance [3–5]. This signal integration
process in immune cells involves many check points that
can involve kinetic proofreading [6–8] or multiple feed-
back loops [9, 10]. In general, feedback allows the system
to adjust its output in response to monitoring itself. Both
positive and negative feedback loops have been found cru-
cial to control the strength and duration of the system’s
activation in order to achieve optimal responses. Such
loops represents a fundamental feature in cell develop-
ment and differentiation [11], hormonal homeostasis [12],
intracellular signalling [13] and in the immune response
[1]. Cells can receive feedback through paracrine signals
coming from their neighbours or from their own autocrine
signals [14, 15]. Since the adaptation to the environment
occurs at the population level, autocrine and paracrine
feedback may play a different role in a cell population
responding to opposing signals, notably as a function of
cell density.
Dendritic cells (DC) are an essential component of the
innate immune system. Acting as the body’s sentinels,
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they are equipped with a diversity of innate receptors,
including pattern recognition receptors such as Toll Like
Receptors (TLRs). Engagement of TLRs by TLR lig-
ands leads to DC maturation, a complex process which
includes migration to draining lymph nodes, secretion of
a diversity of chemokines and cytokines, as well as up-
regulation of major histocompatibility class II (MHC-II)
and co-stimulatory molecules, such as CD80 and CD86
[16]. The latter represent crucial molecular checkpoints
for orchestrating DC-T cell communication, playing a key
role in the activation and expansion of CD4 T cells [17].
A critical question is how the diversity of signals sensed
by DC control the outcome of the DC maturation pro-
gram. In this process, we can discriminate exogenous
signals, i.e the nature and dose of microbial stimuli, and
endogenous signals, such as autocrine factors induced by
exogenous stimulation. When DC are activated by the
bacterial component LPS (exogenous signal), they re-
spond with an increased secretion of TNF-alpha (TNFα)
and interleukin (IL)-10, generally considered as proto-
typical pro- and anti-inflammatory signals, respectively
[18, 19]. As DC are equipped with the corresponding re-
ceptors, both TNFα and IL-10 act as endogenous auto-
regulatory feedback signals that control the output re-
sponse of the cell, and influence the final decision to ini-
tiate an immune response or not. Current and past stud-
ies have mostly studied each of these signals separately.
LPS effect on DC has been extensively studied, includ-
ing at various concentrations revealing dose-dependent
effects [20, 21]. Few studies have addressed the role of the
IL-10 negative feedback loop, showing that it dampens
LPS-induced maturation [22]. TNFα is a DC-activating
pro-inflammatory cytokine [19], but its role as a putative
positive feedback factor on DC remains elusive. Studies
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2of these DC-targeting regulatory signals suggest strong
dependencies and cross-regulatory mechanisms between
LPS, IL-10 and TNFα, but the underlying rules remain
unexplored. Mechanistic understanding requires the in-
tegrated analysis of variations in the three signals level,
and their consequences on the behaviour of the system.
In this study, we combined experimental and theoret-
ical approaches to perform a quantitative dynamic anal-
ysis of LPS, IL-10, and TNFα effects on human DC. We
propose an original model of the interplay between con-
tradictory exogenous and endogenous signals in the con-
trol of DC maturation.
II. RESULTS
A. LPS-induced TNFα and IL-10 differentially
control DC maturation
Upon activation by the TLR ligand LPS, DC undergo
a maturation process leading to an upregulation of cos-
timulatory molecules, such as CD86, but also production
of pro- and anti-inflammatory cytokines. First, we mea-
sured the production of TNFα and IL-10 in response to a
standard LPS concentration of 100 ng/ml. The secretion
of TNFα was more rapid and was significant already af-
ter 2 hours, while IL-10 was detected only after 4 hours
following LPS stimulation (Fig1A). After 4 hours , both
cytokines were detected concomitantly in the cellular su-
pernatant (Fig. 1A). TNFα and IL-10 reached concen-
trations of 3.3 ng/ml and 0.18 ng/ml, respectively after
6 hours (Fig 1A). In order to address the contribution
of these two endogenous cytokines on DC maturation,
we monitored CD86 using flow cytometry, in the pres-
ence and absence of blocking antibodies (Ab) to TNFα
or IL-10(Fig. 1B). LPS induced significant upregulation
of CD86, consistent with an increase in DC maturation
(Fig. 1B). Blocking the IL-10 loop induced a significant
increase in CD86 expression. This suggested that IL-
10 had a dominant negative effect in controlling LPS-
induced DC maturation.
B. LPS dose determines the endogenous IL-10 and
TNFα control of DC maturation
Microbial-derived signals occur at various concentra-
tions in infected tissue, in relationship to the in situ
microbial load. This process is also linked to microbial
clearance, which induces a local decrease in microbial sig-
nals. First, we addressed the impact of various LPS doses
on endogenous TNFα and IL-10 production (Fig. 2A).
Both cytokines exhibited a similar LPS dose-dependent
pattern, reaching maximum levels at a LPS concentra-
tion of 100 ng/ml (Fig. 2A).
Given that TNFα and IL-10 co-exist at variable LPS
concentrations, we asked whether LPS levels impact the
way these endogenous signals are being integrated by DC.
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FIG. 1: LPS-induced TNFα and IL-10 differentially
control DC maturation. A. Secretion of the cytokines
TNFα (red) and IL-10 (green) is monitored through time
under 100ng.mL−1 LPS stimulation. B. CD86 fluorescence
of cellular populations is increased by the presence of LPS
in the medium. Blocking the regulatory loops has no effect
when cells are not stimulated when blocking IL-10 pathway
increases DC activation. As a control for the non blocking
condition, culture with an isotypic antibody does not alter
CD86 levels. Bars show the expectation of the log normal
distribution, error bars the standard error of the mean of the
log normal distributions. Statistical significance of the results
is is assessed using Welch’s t-test in logarithmic space.
To address this question, we cultured DC in the presence
or absence of blocking Abs to the TNFα and IL-10 recep-
tors (TNFR and IL10R) while stimulating them with dif-
ferent concentrations of LPS achieved by serial dilutions
(Fig. 2B). As for the standard LPS dose, DC maturation
was quantified by CD86 expression 24 hours following
LPS activation. When none of the loops were altered
(no blocking or IgG control), the level of activation in-
creased with LPS concentration and reached a plateau
for sufficiently high LPS doses (∼ 100ng/ml) (blue curve
in Fig. 2B). Blocking the pro-inflammatory TNFα loop
led to a decreased expression of CD86 (red curve in
Fig. 2B), while blocking the anti-inflammatory IL-10 loop
led to an increased expression of CD86 (green curve in
Fig. 2B). However, TNFα loop-blocking decreased CD86
levels mostly at LPS concentrations lower than 10 ng/ml
(red curve in Fig. 2B). By contrast, the impact of IL-10
loop-blocking on CD86 expression was constant along a
wide spectrum of medium to high LPS doses, but absent
at low LPS doses (green curve in Fig. 2B). The impact
of the two opposite/contradictory loops differed not only
in the directionality of the effect but also in mode of the
effect: blocking the TNFα loop shifted the EC50 (half
maximal effective concentration) of the response towards
3higher LPS dose, while blocking the IL-10 loop affected
mainly the amplitude of the response, which significantly
increased in the presence of IL-10 blocking compared to
its value in the absence of any blocking.
DC maturation with or without blocking the loops
in the different LPS doses was quantified using the ex-
pression of a second maturation marker CD83. The
expression of this marker also increased with increas-
ing LPS dose (Fig. S1). Blocking the TNFα loop led
to a similar trend as with CD86, with a strong effect
at low LPS doses, and weaker effect at high LPS doses
(Fig. S1). Although both maturation markers were sig-
nificantly upregulated by LPS, their distribution across
the DC population was different. While CD86 demon-
strated a unimodal distribution, CD83 demonstrated a
bi-modal one (Fig. S2). In addition to surface markers,
blocking the loops also had a significant effect on cytokine
secretion (Fig. 2C and D). Importantly, the TNFα and
IL-10 loops reciprocally affected each other, as blocking
the IL-10 loop increased TNFα secretion (green curve
in Fig. 2C compared to the other curves), and blocking
of the TNFα loop strongly decreased IL-10 production
(red curve in Fig. 2D). This suggests potential cross-
regulation of TNFα and IL-10 through DC.
C. Modulated bottleneck model explains DC
maturation control by opposing endogenous and
exogenous signals
In order to qualitatively understand the mechanism
behind microbial-induced signal integration in DC, we
used the above experimental observations to built a min-
imal phenomenological steady state mathematical model
of CD86 response to LPS stimulation. From Fig. 2B we
see that the CD86 response follows a sigmoidal depen-
dence on LPS concentration, which we denote as L and
saturates at high LPS level. Additionally, both IL-10
(denoted as I) and TNFα (T) expressions are sigmoidal
functions of LPS (Fig. 2C and D and see Materials and
Methods Eqs. 1-4). As we noted above, TNFα upregu-
lates IL-10 expression, while IL-10 downregulates TNFα
secretion (Fig. 2C and D). To avoid behavior that is not
observed in the data, we assume there is a basal expres-
sion level of both TNFα and IL-10, even in the absence
(presence) of the regulator. Results of blocking IL-10
show that additionally to repressing TNFα, IL-10 also
decreases the amplitude of the response. Lastly, it has
previously been shown that TNFα alone, in the absence
of LPS, activates and induces DC maturation. This ob-
servation suggested that TNFα does not just act down-
stream of LPS and changes the EC50 solely by trans-
mitting the LPS activation signal, but that TNFα and
LPS act through a common intermediate in an additive
way creating a bottleneck. This last assumption is the
main idea behind our model: LPS and TNFα signals are
integrated in the expression of one regulatory molecule.
The expression of CD86 itself is not regulated directly by
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FIG. 2: LPS dose determines the endogenous IL-10
and TNFα control of DC maturation. A. Titration of
TNFα and IL-10 concentrations(ng.mL−1) for a wide range
of LPS doses. Increasing LPS doses increase both TNFα
(red) and IL-10 (green) secretion levels. B. Activation of DC
is monitored by flow-cytometry labeling the co-stimulatory
molecule CD86. CD86 mean log-fluorescence (MLF) is shown
for a range of LPS concentration incubated with isotypic con-
trol (blue), anti-TNFR (red) or anti-IL-10R (green) antibod-
ies. CD86 has a sigmoidal dependence on LPS doses. Block-
ing IL-10 increases the maximal activation level while block-
ing TNFα decreases the sensitivity. Cytokine response of DC
in different conditions, medium (dark blue), isotypic control
(blue), anti-TNFR (red), anti-IL-10R antibodies, is measured
for different doses of LPS. C. Blocking IL-10 increases TNFα
secretion D. Blocking TNFα decreases IL-10 secretion
TNFα and LPS, but by the concentration and status of
this central integrator (Fig. 3).
A schematic representation of the effective regulatory
pathway described above is shown in Fig. 3. A central
signal integrator combines the two pro-inflammatory sig-
nals, TNFα and LPS, in a single common pathway mak-
ing this integrator the key regulator of DC decision. The
integrator acts as a molecular bottleneck for the pro-
inflammatory signals (see Fig. 3): it responds to increases
4in the pro-inflammatory signal concentrations only until
a certain total concentration. This concentration can be
reached either purely by TNFα or purely by LPS, or by
their combination (see Fig. 4B). Above this total concen-
tration, set by the effective EC50 parameter, the response
is saturated and increasing pro-inflammatory signals has
no effect on the input. Without the bottleneck effect
of the central integrator, the TNFα and LPS pathways
would independently control the CD86 response. In this
case blocking the TNFα loop would not change the EC50
of the response to LPS, and adding more LPS while the
TNFα loop was blocked would lead to an increased acti-
vation even for infinitely high LPS doses.
The concentration of the integrator molecule controls
the amplitude of the response, which is further modu-
lated downstream by the IL-10 anti-inflammatory signal
(Fig. 3 and Fig. 4B). A plumbing analogy helps illus-
trate the role of the bottleneck and downstream anti-
inflammatory regulation: there is a very high source of
water distributed to each house, but the amount of avail-
able water is limited by the throughput capacity of the
main pipeline (this is the bottleneck that regulates the
amount of pro-inflammatory signals – see Fig. 4B). How-
ever when you take a shower, you can regulate the water-
flow directly at the faucet (this is the inhibitory action
of IL-10). In the absence of IL-10, the bottleneck still
limits the scale of the inflammatory response. IL-10 can
further downregulate it.
The bottleneck model reproduces all the experimen-
tally observed features in Fig. 1B. It further predicts the
combined effect of blocking both the IL-10 and TNFα
loops (Fig. 4A). We graphically represent the predictions
of the model for the four blocking conditions at low and
high LPS concentrations in Fig. 4B. At high LPS dose
the bottleneck limits the signaling of the master integra-
tor, regardless of whether both TNFα or LPS are sensed
or only LPS, and the IL-10 further reduces the strength
of the response. At low LPS concentrations the effect
of the bottleneck is reduced but IL-10 further modulates
the output. We experimentally validated the bottleneck
model by blocking both loops simultaneously in LPS
stimulated DC. In agreement with the prediction, the
condition in which both loops were blocked affected the
CD86 IC50 expression similarly to blocking the TNFα
loop only in lower LPS dose (Fig. 4C). At higher LPS
doses the CD86 amplitude increased similarly to block-
ing IL-10 alone, also in agreement with the model pre-
dictions.
D. Paracrine signalling predominantly controls DC
maturation
DC in our experiment, as in the organism, are not iso-
lated and signal integration depends on the diffusion of
cytokines: a cytokine produced by a given cell could be
picked up by a receptor on the surface of this same cell
(autocrine loop) or by a neighboring cell (paracrine loop).
LPS
TNFαIL-10
bottleneck
CD86
FIG. 3: Cartoon of the modulated bottleneck model.
Arrows represent functional (not necessarily direct) interac-
tions. LPS controls the activation of the bottleneck, as well
as IL-10 and TNFα. TNFα and LPS act through a common
bottleneck for the activation of DC, while IL-10 modulates the
activation level downstream. The model also includes partial
mutual regulation of TNFα and IL-10.
Since we cannot directly measure inter-cellular communi-
cation with single molecule resolution, we designed and
performed cell dilution experiments to get insight into
DC communication at a larger spatial scale. At high cel-
lular concentrations, cells can sense signals from nearby
cells (Fig. 5A), and at large dilutions, only from them-
selves (Fig. 5C). Large dilution conditions correspond to
pure autocrine signaling. This experiment is based on
the assumption that the effect of a purely paracrine loop
will decrease as cells are diluted, while a purely autocrine
loop will not be sensitive to dilution of the population
density. Since the effect of the TNFα feedback loop was
observed at low LPS concentrations, whereas the IL-10
feedback was active at high LPS concentrations, we per-
formed dilution experiments at two distinct LPS doses.
The role of autocrine and paracrine signaling has recently
been addressed in immune cells [23].
To predict the behavior of the DC response in the dilu-
tion experiments we combined our phenomenological bot-
tleneck model (Fig. 3) with diffusion-based estimates for
the probabilities of autocrine and paracrine absorption in
an effective heterogeneous medium [24](see Materials and
Methods for details). Using previously measured kinetic
and geometric parameters (see Materials and Methods),
the theoretical calculation predicts that a large fraction of
the signaling is paracrine in nature. In Fig. 5E and G we
plot the predictions for the mean log CD86 expression at
a low and high LPS concentration as a function of the cell
concentration. If most of the signaling is paracrine in na-
ture, as we see that at high LPS concentrations (Fig. 5G),
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FIG. 4: Bottleneck model explains DC maturation control by opposing endogenous and exogenous signals. A.
Fraction of activation of DC population for a range of LPS doses as predicted by the steady state model. Using this model
we predict the qualitative behavior of the system when both regulatory loops are not functional. B. Schematic representation
of the outcome of the steady state bottleneck model C. CD86 mean log-fluorescence (MLF) for a range of LPS stimulation
strength. Blocking both regulatory loops grants us a good test of the validity of our model. The model offers good qualitative
agreement with the data in every condition.
with increasing cell dilutions all the blocking conditions
converge to nearly the same activation levels, equal to
the levels predicted in the case when all the loops are
non-functional (orange curve in Fig. 5B and G). For very
low cell density we expect the paracrine feedback loops
to have no effect on CD86 expression and all feedback
takes place by autocrine loops. Measurements of ligand
affinity of TNFα and IL-10 to their respective membrane
receptors [25–27] show that TNFα has a greater affin-
ity for its receptor than IL-10 does. We thus predict
6that TNFα autocrine fraction should be greater than IL-
10. Since the effect of the TNFα feedback is observed
at low LPS concentrations, and the IL-10 feedback at
high LPS concentrations, we expect the convergence of
the curves corresponding to different conditions at low
LPS concentrations to be less pronounced than at high
concentrations. Our model predicts (see Fig. 5E) that
the curves corresponding to blocking the TNFα loop do
not converge to those where the TNFα is active at high
dilutions for low LPS concentration.
To experimentally assess the effect of dilutions on the
loops we activated DC with either low (1 ng/ml) or high
(100ng/ml) LPS in different cell dilutions with the ini-
tial culture concentration being 106cells.mL−1 (Fig. 5F
and H). In agreement with our model we could observe
that at both low and high LPS doses all conditions were
converging to the same amount of activation. Because of
the saturation effect we could not observe a slower con-
vergence for the case of a blocked TNFα loop for high
LPS dose, however it was observable for low LPS dose
(Fif5F). In the case of the lower LPS dose, in which the
TNFα loop plays a more specific role, we observed that
despite serial dilution, the effect of blocking the loop was
maintained, at least to some extent, suggesting the ex-
istence of an autocrine signaling. Interestingly, in the
higher dose of LPS, the effect of IL-10 loop was rather
sensitive to dilutions, suggesting that in a context of high
microbial load IL-10 acts in a paracrine manner.
III. DISCUSSION
Innate immune recognition is key to promote an ef-
ficient anti-microbial immune response, but also needs
to be controlled, in order to avoid immunopathology. It
is known that immune activating and immune dampen-
ing signals are both rapidly produced and co-exist within
any inflamed tissue [2]. However, the interplay between
exogenous microbial signals, and endogenous pro- and
anti-inflammatory signals has not been formalized in an
integrated manner. This is critical to the decision mak-
ing of the immune response, as it is driven by multiple
dynamic signals, conveying different types of information
to innate immune cells. By combining experiments with
modeling, we showed that the final response of the DC
population relies on integrating the initial signal with
the induced pro- and anti-inflammatory responses using
feedback loops. The integration is based on two steps:
first the pro-inflammatory signals are integrated through
a bottleneck and then the amplitude of the result is fur-
ther modulated by the anti-inflammatory signal. The
key element of this integration occurs at the signal bot-
tleneck, which controls the effective concentration range
(EC50) of the response to LPS and limits the maximum
pro-inflammatory response. The anti-inflammatory regu-
lation that follows is mostly paracrine, as opposed to the
bottleneck integration that has an autocrine component,
suggesting that the final response is modulated based on
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FIG. 5: Discriminating autocrine from paracrine
loops using dilutions. A. and B. Cartoon and pre-
diction of our steady state model with diffusion for high
cell concentration. C. and D.Cartoon and prediction of our
steady state model with diffusion for very low cell concentra-
tion. E.Prediction of our steady state model with diffusion
on DC activation for a weak LPS stimuli. Computing the
expected activation for a range of cell concentrations gives
us a qualitative prediction for serial dilutions experiments.
F. Corresponding dilution experiment with low dose of LPS
(1ng.mL−1). G. Model prediction for high dose of LPS. H.
Corresponding dilution experiment with high dose of LPS
(100ng.mL−1). LPS concentration values used for the model
predictions in E. and G. are shown with red dashed lines in
B. and D..
the population level response.
Bottleneck signal integration in molecular systems
have mostly been proposed for the integration of two
positive signals. They were suggested as a means for
TNFα activation [28]. Here we propose that a bottle-
neck is the essential component in making the decision
to the response in the presence of two opposing signals:
7IL-10 and TNFα. Since the negative regulation by IL-
10 acts after the bottleneck, it regulates the maximum
level of activation, while the positive TNFα acts before
the bottleneck thereby affecting the activation threshold.
The two opposing signals thus control distinct aspects of
the dose response. This feature is independent of the fact
that the two signals have opposing effects: the possibil-
ity of additional pre- or post-bottleneck regulation would
have the same effect on two positive signals.
A natural candidate for this bottleneck integrator is
the widely studied [29] nuclear factor NFκ B: several
studies demonstrated how LPS and TNFα trigger NFκ
B nuclear translocation [30]. Additionally the saturation
effect observed in our data was also seen when looking
at NFκ B nuclear translocation due to the limited and
constant amount of NFκ B[10].
Additionally to the main modes of signal integration
based on the bottleneck and IL-10 repression, TNFα ac-
tivates IL-10 expression, while IL-10 represses TNFα.
These secondary interactions do not change the basic flow
of signal integration, but are predicted by the model to
produce a maximum in the CD86 at intermediate LPS
concentrations (Fig. 4A). Since LPS activates both IL-10
and TNFα, repression of TNFα slightly shifts the EC-
50 of the response to larger LPS concentrations, while
activation of IL-10 results in a larger moderation of the
response than in the absence of TNFα for high LPS con-
centrations.
The presented results are population averages over
multiple independent measurements. The fluorescence
distributions plotted in Fig. S2 show a large heterogene-
ity in the population, indicating that particular cells can
have very different responses. The error bars indicate the
standard error of the mean over multiple experiments.
The measurement noise is impossible to distinguish from
the natural heterogeneity of the response in the popula-
tion. Given this heterogeneity, the mean CD86 response
in the double blocked mutant is consistent with the the-
oretical prediction.
Dendritic cells often are surrounded by other dendritic
cells and, through secreting signaling molecules, commu-
nicate with each other to make a decision at the pop-
ulation level. This collective decision making process
can help make the right readout in a noisy environment
thus reducing response variability as for wound healing
[31]. By sharing their response, cells in a population can
confirm initial measurements by sensing the signals that
their neighbors secrete. Alternatively, cells could simply
use the feedback loops to amplify their own initial signal
to accelerate their response.
Previous experiments have highlighted the difference
between population and single cell measurements in
TNFα responses [30]. The nature of the signal (paracrine
or autocrine) controls the spatial range of the responding
cells and determines the lengthscale on which the deci-
sion is made. Feedback loops are necessary elements for
integrating population-level signals. The signalling range
controls whether there is population level averaging, or
whether each cell only listens to itself. Here, by using
a combination of dilution and fluorescence experiments
with modelling, we show that the anti-inflammatory IL-
10 signal is paracrine and long range, as opposed to the
autocrine and short range pro-inflammatory TNFα sig-
nal. Cells rely on local signals to detect bacterial signals,
but integrate anti-inflammatory signals from anywhere
in the population to modulate their response.
Such a localized pro-inflammatory response can be use-
ful in the case of an infection: cells that are further away
from the source of the signal do not need to respond.
In view of their signalling ranges, autocrine or paracrine
feedback loops have different roles: autocrine signaling
modifies the strength of response to LPS of the cell itself,
while paracrine signaling is used to transmit information
to neighboring cells that may not have been exposed to
LPS directly. Such a combination of local, excitatory
feedback with global, inhibitory regulation has been sug-
gested as a general way to sense differences in spatial
concentration profiles, and has been proposed as a mech-
anism for detecting spatial concentration gradients in the
slime mold Dictyostelium [32–34], or more recently for
wound healing [31] and in the context of morphogenesis
of mammary epithelial cells in response to a gradient of
the Epidermal Growth Factor [35]. Our results extend
this concept to the immune system following innate mi-
crobial sensing.
In summary, in this joint experimental and theoreti-
cal study we quantified how a cell makes decisions about
the appropriate response to a given concentration of the
bacterial signal LPS in the environment, and as a re-
sult whether to initiate an inflammatory response or not.
More broadly, the mechanisms described give a way to
integrate information and make decisions in the presence
of conflicting signals. Furthermore we show how simple
biophysical models give us insights into cell-cell commu-
nication in cell density regimes that are inaccessible by
single-cell microscopy [14, 15].
IV. MATERIALS AND METHODS
A. Monocyte-derived dendritic cells generation
and activation
Fresh blood samples collected from healthy donors
were obtained from Hoˆpital Crozatier E´tablissement
Franc¸ais du Sang (EFS), Paris, France, in conformity
with Institut Curie ethical guidelines. PBMCs were iso-
lated by centrifugation on a Ficoll gradient (Ficoll-Paque
PLUS, GE Healthcare Life Sciences). Monocytes were
selected using antibody-coated magnetic beads and mag-
netic columns according to manufacturers instructions
(CD14 MicroBeads, Miltenyi Biotec). To generate im-
mature DC, CD14+ cells were cultured for 5 days with
IL-4 (50 ng/mL) and GM-CSF (10 ng/mL) in RPMI 1640
Medium, GlutaMAX (Life Technologies) with 10% FCS.
Monocyte-derived DC were pre- treated for one hour with
8mouse IgG1 (20 g/mL, R&D Systems), mouse anti-IL10R
blocking antibody (10 µ g/mL, R&D Systems) or mouse
anti-TNFα Receptors 1 and 2 (10 µ g/mL, R&D Sys-
tems) and then cultured with medium or LPS ( Invivo-
gen) for additional 24 hours. Cells were stained for 15
min at 4o C using a PE-anti-Human-CD86 (clone 2331,
BD), or with the corresponding isotype. Cells were ana-
lyzed on a Fortessa instrument (BD Biosciences).
B. Dilution experiments
The dilution experiments were carried out following
the same procedure as described above, but with 1:3, 1:9
and 1:27 fold dilutions.
C. Phenomenological bottleneck model
The bottleneck model for signal integration presented
in Fig. 3 and described in the main text predicts the con-
centration C of the differentiation marker CD86 in terms
of the concentration L of LPS, and the concentration I of
IL-10 and T of TNFα, expressed in fraction of their max-
imal values. Note that IL-10 and TNFα concentrations
depend on L themselves. The experimental observations
are summarized by the minimal phenomenological model:
T =
1
1 + I/(1− β) ×
1
1 + (KT /L)nT
, (1)
I =
1− α+ αT
1 + (KI/L)nI
, (2)
B =
1
1 +
(
KC
L+θT
)nC , (3)
C =
B
1 + I
, (4)
where KT , KI describe the concentrations of LPS at
which TNFα and IL-10, respectively, would reach half
maximal activation in the absence of other regulation.
nT and nI are Hill coefficients describing the effective
steepness of the regulation function. Note that, in addi-
tion to being regulated by LPS, IL-10 and TNF-α also
regulate each other (Eq. 1 and 2). The strength of this
mutual interaction is set by the constants α and β. The
pro-inflammatory signals from LPS and LPS-activated
TNFα are then integrated by activation of a common
intermediate species of concentration B (Eq. 3), which
reaches half-maximal expression at a joined input con-
centration of KC with an effective cooperativity of nC .
θ describes the maximal concentration of TNFα, so that
TNF concentration is given by θT . B is given in arbi-
trary units so that its maximum activation is 1 at satu-
ration. Signal integration through B creates a signaling
bottleneck: at low levels of pro-inflammatory signals the
response B is proportional to the sum of both LPS and
TNFα signals, L and θT , but at high levels large concen-
trations of either LPS or TNFα are sufficient to saturate
the response. The final concentration of CD86, C (Eq. 4)
is modulated downstream by the anti-inflammatory IL-
10 that represses the integrated pro-inflammatory signal,
modulating the amplitude of the response but not the
concentration range of the response. The model is a phe-
nomenological model that captures the relevant features
of the complex interaction network by focusing on the
effective interactions. The parameters, such as the con-
centrations at half maximal expression, do not describe
individual mechanistic molecular interactions, but the ef-
fective outcome of many such reactions.
To calculate the output concentration C as a function
of L, I and T are first determined self-consistently by
solving the system of two equations 1 and 2 for a given
L. Then their values are injected into Eq. 3 and 4 to
obtain C.
D. Ligand diffusion model
Each secreted signaling molecule, TNFα or IL-10, can
have four distinct fates. He can be absorbed by the cell
that emitted it with probability Pauto (autocrine signal-
ing), or by another cell with probability Ppara (paracrine
signaling). It can be degraded in the medium with prob-
ability Pdeg, or left free in solution with probability Pfree.
To estimate the role of autocrine and paracrine sig-
nalling, we use the results derived by Coppey et al [24] for
the probability of autocrine absorption of a ligand. This
result assumes an effective rate with which the secreted
molecule encounters another cell and is absorbed by it,
kabs = 4piDR
2κ/(D +Rκc). This rate depends on the
cell concentration c, the ligand diffusivity D, and on an
effective surface trapping rate κ = konNR/4piR
2, whereR
is the cell radius, NR the number of receptors displayed
at the surface of the cell and kon the rate constant of
the ligand-receptor binding. In addition, molecules are
degraded with rate kdeg, resulting in an effective rate
kb = kabs + kdeg of molecules disappearing from the
medium.
At long times, the probability of autocrine signaling
then reads:
Pauto =
κ
D
R + κ+
√
Dkb
. (5)
This result is valid for times that are longer than the
typical time it takes for the ligand to be recaptured by
the cell that secreted it. In that regime, which is that of
the measurements,
Pfree(t) = e
−kbt(1− Pauto), (6)
Ppara(t) =
kabs
kb
(1− e−kbt)(1− Pauto), (7)
Pdeg(t) =
kdeg
kb
(1− e−kbt)(1− Pauto), (8)
9where we have used Pabs/Pdeg = kabs/kdeg, Pauto +
Ppara + Pfree + Pdeg = 1, and the fact that ligands hav-
ing escaped autocrine absorption have probability e−kbt
of staying in the medium (i.e. not being absorbed by
another cell or degraded) after time t.
The fraction f of ligands that contribute to signaling
after time t is thus the sum of the probabilities of au-
tocrine and paracrine signaling,
f = Pauto + Ppara. (9)
This fraction depends on both the time t since the begin-
ning of the experiment, and the concentration c of cells.
Since IL-10 and TNFα signaling may have different prop-
erties, we define two fractions fI and fT corresponding to
the fraction of IL-10 and TNFα contributing to signaling.
Equations (1)-(4) are then modified to:
T =
1
1 + fII/(1− β) ×
1
1 + (KT /L)nT
, (10)
I =
1− α+ αfTT
1 + (KI/L)nI
, (11)
C =
1
1 +
(
KC
L+θfTT
)nC × 11 + fII . (12)
Each quantity depends on the cell concentration c and
on the time t through fI and fT .
In order to probe the behavior of the system we gath-
ered plausible model parameters from the literature. For
a number of parameters precise estimates were not found
and we used analogue estimates for other systems (e.g
macrophages). These parameters are presented and jus-
tified in the following section and summarized in Table
S1. Because of our focus on the phenomenology of the
model, we did not try to make precise numerical predic-
tions, but rather give qualitative ones. Parameters were
not fitted to the data. They were either taken from the
literature, or picked to reproduce the data qualitatively.
The rate constant for TNFα/TNFr1 and TNFα/TNFr2
association is estimated to be 107 − 108M−1s−1 [25] and
the IL-10 association rate to 105 − 106M−1s−1 [26, 27].
We took a cell radius of 25µm, an initial cell concen-
tration of 106mL−1 before dilution, a diffusion coeffi-
cient D = 102µm2s−1 [24], and the number of receptors
NR = 10
3 − 104 (the number of receptors on dendritic
cells is not known and we use an order of magnitude es-
timate based on macrophages [27, 36–39]). While TNF
degradation rate was measured to be 2× 10−4s−1 [10],
interleukins are classically described as extremely stable,
meaning that measured degradation rates actually cor-
respond to absorption by other cells. We thus assumed
kIL−10deg to be negligible. When DCs were cultured for
24 hours, the delay with which DCs start signalling and
the fact that DCs make decision on a shorter timescale
should be considered. We picked the actual signal inte-
gration time t to be lower than 24h and to be around
10h. Changing this integration time to t = 5h (Fig. S3)
did not affect the model prediction.
These parameter values allow us to estimate that the
majority of the effective signaling is paracrine. TNFα
has a stronger autocrine component, PTNFauto /(P
TNF
auto +
PTNFpara ) = 5–18%, than IL-10, P
IL-10
auto /(P
IL-10
auto + P
IL-10
para ) =
0.1–2.3%, in the range of concentration experimentally
tested.
We used the estimates of the probability of auto- vs
paracrine signaling combined with our bottleneck model
to predict the response of CD86 at different dilutions.
We simulated a population of cells in a medium with
low (L = 4.7ng · L−1) and high (L = 100ng · L−1) LPS
concentrations and used the properties of autocrine and
paracrine signaling derived above to estimate the popula-
tion level response at different dilution. The parameters
used for the diffusion model and the corresponding ref-
erences are listed in Table S1.
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VI. SUPPLEMENTARY INFORMATION
Parameter Value Ref
β 0.6 -
α 0.6 -
ϑ 20 -
KT 5 -
KI 0.8 -
KC 1.8 -
nT 1.5 -
nI 1.5 -
nC 2.5 -
D 10−10 m2.s−1 [24]
R 25 µm [24]
NR 10
4 [27, 36–39]
kTNFαon 10
8 M−1.s−1 [25]
kIL−10on 10
6 M−1.s−1 [26, 27]
kTdegNF 2× 10−4.s−1 [10]
kIL−10deg 0 -
TABLE S1: Model parameters table
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FIG. S1: CD83 mean log-fluorescence (MLF) is shown for
a range of LPS concentration incubated with isotypic control
(blue), anti-TNFR (red) or anti-IL-10R (green) antibodies.
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FIG. S2: Distribution of CD86 (A.) and CD83 (B.) log-
fluorescence for zero (blue), 1 ng/ml (orange) and 100 ng/ml
LPS concentrations.
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FIG. S3: Diffusion model prediction for 5h of effective mea-
surement.
